Health & Medicine

The Museum's collections of medical science artifacts represent nearly all aspects of health and medical practice. Highlights include early X-ray apparatuses, such as one of Wilhelm Roentgen's tubes, penicillin mold from Alexander Fleming’s experiments, and Jonas Salk's original polio vaccine. More recent acquisitions include the first artificial heart implanted in a human, the earliest genetically engineered drugs, and materials related to David, the "Bubble Boy." Other artifacts range from artificial limbs and implant devices to bloodletting and dental instruments, beauty products, and veterinary equipment. The contents of a medieval apothecary shop and an 1890s drugstore form part of the collections, along with patent and alternative medicines. The collections also document the many differing perspectives on health and medical issues, from patients, family members, doctors, nurses, medical students, and out-of-the-mainstream health practitioners.

The indications or uses for this product as provided on its packaging:An antacid in heartburn, sour stomach, uric acid diathesis; aids digestion; used for obesity in connection with Kissingen saltsCurrently not on view
Description
The indications or uses for this product as provided on its packaging:
An antacid in heartburn, sour stomach, uric acid diathesis; aids digestion; used for obesity in connection with Kissingen salts
Location
Currently not on view
Date made
1906-1918
1906-1908
maker
Eli Lilly and Company
ID Number
MG.M-12151.02
accession number
271464
catalog number
M-12151.02
Currently not on view
Location
Currently not on view
date made
ca 1981
product expiration date
1983-04-01
maker
Eli Lilly and Company
ID Number
1982.0153.01
accession number
1982.0153
catalog number
1982.0153.01
Currently not on view
Location
Currently not on view
date made
ca 1962
maker
Eli Lilly and Company
ID Number
MG.M-10250.04
catalog number
M-10250.04
accession number
241449
Currently not on view
Location
Currently not on view
date made
ca 1962
maker
Eli Lilly and Company
ID Number
MG.M-10250.03
catalog number
M-10250.03
accession number
241449
Currently not on view
Location
Currently not on view
date made
ca 1930
maker
Eli Lilly and Company
ID Number
MG.M-02894.05
catalog number
M-02894.05
accession number
111796
Currently not on view
Location
Currently not on view
maker
Eli Lilly and Company
ID Number
MG.M-09648
catalog number
M-09648
accession number
233571
This metal case contains two metal needles, and a graduated glass syringe with an inscription that reads in part “Lilly / ILETIN SYRINGE.” Iletin was the Eli Lilly & Co. trade name for insulin. The inscription on the case reads “Lilly / ASEPTIC.”Currently not on view
Description
This metal case contains two metal needles, and a graduated glass syringe with an inscription that reads in part “Lilly / ILETIN SYRINGE.” Iletin was the Eli Lilly & Co. trade name for insulin. The inscription on the case reads “Lilly / ASEPTIC.”
Location
Currently not on view
date made
ca 1930
maker
Eli Lilly and Company
ID Number
MG.M-02888
catalog number
M-02888
accession number
111796
Humulin is human insulin used for treating diabetes. Prior to its development, diabetics used insulin isolated from pig and cow pancreases.
Description (Brief)
Humulin is human insulin used for treating diabetes. Prior to its development, diabetics used insulin isolated from pig and cow pancreases. Developed by Genentech, the first American biotechnology company, Humulin was licensed to Eli Lilly and became the first marketable product created through recombinant DNA technology. Its licensing by the FDA in October 1982 also made it the first recombinant pharmaceutical approved for use in the United States.
Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human insulin are inserted into bacteria. Bacteria produce insulin, which is harvested and used as the active ingredient in Humulin.
Humulin 70/30 is an intermediate-acting insulin combined with the more rapid onset of action of regular human insulin. The duration of activity may last up to 24 hours following injection.
Object is a sealed white cardboard box with black and red printing.
Location
Currently not on view
date made
before 1995
maker
Eli Lilly and Company
ID Number
2012.0046.44
accession number
2012.0046
catalog number
2012.0046.44
Currently not on view
Location
Currently not on view
date made
ca 1956
maker
Eli Lilly and Company
ID Number
1980.0076.017
accession number
1980.0076
catalog number
1980.0076.17
Humulin is human insulin used for treating diabetes. Prior to its development, diabetics used insulin isolated from pig and cow pancreases.
Description (Brief)
Humulin is human insulin used for treating diabetes. Prior to its development, diabetics used insulin isolated from pig and cow pancreases. Developed by Genentech, the first American biotechnology company, Humulin was licensed to Eli Lilly and became the first marketable product created through recombinant DNA technology. Its licensing by the FDA in October 1982 also made it the first recombinant pharmaceutical approved for use in the United States.
Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human insulin are inserted into bacteria. Bacteria produce insulin, which is harvested and used as the active ingredient in Humulin.
Humulin R is considered to be "regular" insulin and has had nothing added to change the speed or length of its action. It takes effect rapidly and has a relatively short duration of activity (6 to 8 hours) as compared with other insulin formulations.
Object consists of a white cardboard box with black and red printing. Box contains two product inserts and one round clear glass bottle with an orange plastic cap and a white label. Bottle contains a yellowish, clear solution.
Location
Currently not on view
date made
1987
maker
Eli Lilly and Company
ID Number
1987.0790.03
accession number
1987.0790
catalog number
1987.0790.03
Currently not on view
Location
Currently not on view
date made
1920s
ca 1923
maker
Eli Lilly and Company
ID Number
1982.0498.03
catalog number
1982.0498.03
accession number
1982.0498
Currently not on view
Location
Currently not on view
maker
Eli Lilly and Company
ID Number
1982.0498.09
accession number
1982.0498
catalog number
1982.0498.09
Humulin is human insulin used for treating diabetes. Prior to its development, diabetics used insulin isolated from pig and cow pancreases.
Description (Brief)
Humulin is human insulin used for treating diabetes. Prior to its development, diabetics used insulin isolated from pig and cow pancreases. Developed by Genentech, the first American biotechnology company, Humulin was licensed to Eli Lilly and became the first marketable product created through recombinant DNA technology. Its licensing by the FDA in October 1982 also made it the first recombinant pharmaceutical approved for use in the United States.
Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human insulin are inserted into bacteria. Bacteria produce insulin, which is harvested and used as the active ingredient in Humulin.
Humulin L is an intermediate-acting insulin with a slower onset of action than regular insulin and a longer duration of activity (up to 24 hours). Due to declining use of longer-acting insulins, Humulin L was discontinued in 2005.
Object is a sealed white cardboard box with black and red printing.
Location
Currently not on view
date made
before March 1995
maker
Eli Lilly and Company
ID Number
2012.0046.46
accession number
2012.0046
catalog number
2012.0046.46
Currently not on view
Location
Currently not on view
date made
after 1936
maker
Eli Lilly and Company
ID Number
1982.0498.17
catalog number
1982.0498.17
accession number
1982.0498
Currently not on view
Location
Currently not on view
date made
ca 1940
maker
Eli Lilly and Company
ID Number
1982.0498.15
catalog number
1982.0498.15
accession number
1982.0498
Currently not on view
Location
Currently not on view
date made
ca 1944
maker
Eli Lilly and Company
ID Number
MG.M-05202
catalog number
M-05202
accession number
166920
Humulin is human insulin used for treating diabetes. Prior to its development, diabetics used insulin isolated from pig and cow pancreases.
Description (Brief)
Humulin is human insulin used for treating diabetes. Prior to its development, diabetics used insulin isolated from pig and cow pancreases. Developed by Genentech, the first American biotechnology company, Humulin was licensed to Eli Lilly and became the first marketable product created through recombinant DNA technology. Its licensing by the FDA in October 1982 also made it the first recombinant pharmaceutical approved for use in the United States.
Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human insulin are inserted into bacteria. Bacteria produce insulin, which is harvested and used as the active ingredient in Humulin.
Humulin L is an intermediate-acting insulin with a slower onset of action than regular insulin and a longer duration of activity (up to 24 hours). Due to declining use of longer-acting insulins, Humulin L was discontinued in 2005.
Object consists of a white cardboard box with black and red printing. Box contains two product inserts and a round, clear glass bottle with an orange plastic cap and white label. Bottle contains a white substance suspended in a clear solution.
Location
Currently not on view
date made
1987
maker
Eli Lilly and Company
ID Number
1987.0790.04
accession number
1987.0790
catalog number
1987.0790.04
Currently not on view
Location
Currently not on view
date made
ca 1953
expiration date
1953-10-27
maker
Eli Lilly and Company
ID Number
1985.0475.848
accession number
1985.0475
catalog number
1985.0475.848
Currently not on view
Location
Currently not on view
maker
Eli Lilly and Company
ID Number
1985.0475.060
accession number
1985.0475
catalog number
1985.0475.060
accession number
1985.0475
Currently not on view
Location
Currently not on view
date made
ca 1951
expiration date
1951-04-01
maker
Eli Lilly and Company
ID Number
1985.0475.849
accession number
1985.0475
catalog number
1985.0475.849
Currently not on view
Location
Currently not on view
date made
ca 1952
expiration date
1952-10-17
maker
Eli Lilly and Company
ID Number
1978.0882.37
accession number
1978.0882
catalog number
1978.0882.37
Currently not on view
Location
Currently not on view
date made
ca 1940
maker
Eli Lilly and Company
ID Number
MG.M-04898.03
catalog number
M-04898.03
accession number
156188
Currently not on view
Location
Currently not on view
date made
ca 1953
expiration date
1953-09-19
maker
Eli Lilly and Company
ID Number
1978.0882.36
accession number
1978.0882
catalog number
1978.0882.36
Currently not on view
Location
Currently not on view
date made
ca 1952
expiration date
1952-05-13
maker
Eli Lilly and Company
ID Number
1978.0882.07
accession number
1978.0882
catalog number
1978.0882.07

Our collection database is a work in progress. We may update this record based on further research and review. Learn more about our approach to sharing our collection online.

If you would like to know how you can use content on this page, see the Smithsonian's Terms of Use. If you need to request an image for publication or other use, please visit Rights and Reproductions.